Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
75 studies found for:    Sestamibi
Show Display Options
Rank Status Study
1 Recruiting Tc99m Sestamibi Molecular Breast Imaging
Condition: Breast Cancer
Interventions: Procedure: Molecular Breast Imaging (MBI);   Drug: Tc99m sestamibi
2 Completed
Has Results
PET Imaging With Tc-94m Sestamibi to Assess Resistance to Chemotherapy
Condition: Cancer
Interventions: Drug: Tariquidar;   Drug: Tc-94m Sestamibi
3 Recruiting Study of 99mTc-Sestamibi SPECT/CT Imaging for the Preoperative Diagnosis of Renal Oncocytoma
Condition: Clinical T1 Renal Mass
Intervention: Other: Preoperative 99mTc-Sestamibi SPECT/CT
4 Completed Evaluation of the Effect of Fasting and Exercise on Uptake of Tc-99m Sestamibi in Breast Tissue
Condition: Molecular Imaging [E01.370.350.557]
Interventions: Dietary Supplement: Meal;   Other: Exercise;   Radiation: Sestamibi;   Drug: Caffeine Tablet;   Other: External Heating
5 Completed Stress and Rest Myocardial Tomoscintigraphies Using Mono- or Double-isotope Protocol With a Semiconductor Camera
Condition: Myocardial Perfusion
Interventions: Procedure: Tomoscintigraphy with D.SPECT camera (SPECTRUM Dynamics®, Israel);   Drug: 99mTc-Sestamibi;   Drug: Thallium-201
6 Not yet recruiting Multimodality Breast Imaging for the Assessment of Tumor Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer Patients
Conditions: Breast Cancer;   Malignant Neoplasm of Breast
Interventions: Procedure: Dynamic Contrast Enhanced Molecular Resonance Imaging (DCE-MRI);   Procedure: Tc99m Sestamibi Molecular Breast Imaging (MBI);   Drug: 99mTc Sestamibi
7 Completed
Has Results
Rapid Stress/Rest Single-Day Tc-99m Sestamibi Myocardial Single Photon Emission Computed Tomography
Condition: Coronary Artery Disease
Intervention: Other: low-dose stress MPI SPECT
8 Unknown  The Comparison of the Necessity of Repeat Myocardial Perfusion SPECT Studies Between Tc-99m Tetro and Tc-99m Mibi
Condition: Myocardial Ischemia
9 Completed A Trial to Determine Radiation Exposure to Organs and Assess the Safety of CARDIOLITE® in Pediatric Subjects
Condition: Kawasaki Disease
Intervention: Drug: Technetium Tc99m Sestamibi
10 Terminated Evaluation of Magnetic Resonance Imaging (MRI) vs Molecular Breast Imaging (Tc-MBI) in Breast Cancer Patients
Condition: Breast Cancer
Intervention: Other: Sestamibi (Tc-MBI) scan of the breast
11 Completed
Has Results
Paclitaxel and CBT-1(Registered Trademark) to Treat Solid Tumors
Conditions: Cervical;   Ovarian;   Lung;   Breast;   Renal
Interventions: Drug: paclitaxel;   Drug: CBT-1(Registered Trademark);   Radiation: Tc 99m sestamibi
12 Completed
Has Results
A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease
Condition: Kawasaki Disease
Intervention: Drug: Sestamibi
13 Completed
Has Results
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Condition: Coronary Artery Disease
Interventions: Drug: Flurpiridaz F18;   Drug: 99mTechnicium (sestamibi or tetrofosmin)
14 Completed Hormonal Effects on Tc-99m Sestamibi Uptake in the Breast
Condition: Breast Cancer
15 Unknown  Investigation of High Resolution Nuclear Breast Imaging Camera (MBI) in Patients Administered Tc-99m Sestamibi (ROSE)
Condition: Breast Lesions
16 Completed
Has Results
Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer
Conditions: Lung Neoplasms;   Ovarian Neoplasms;   Cervix Neoplasms;   Renal Neoplasms
Interventions: Drug: docetaxel;   Drug: tariquidar;   Other: 99mTc-sestamibi imaging
17 Active, not recruiting Surgeon Compared to Nuclear Radiology Readers for Tc-99m Sestamibi Scans for Parathyroid Disease
Condition: Parathyroid Disease
18 Completed Effect of Surgery and Radiation Therapy on Tc-99M Sestamibi Uptake Patterns in Molecular Breast Imaging
Condition: Breast Cancer
Intervention: Device: Molecular Breast Imaging
19 Not yet recruiting Study of Muscle Energy Metabolism in RCC Patients Treated With Sunitinib
Conditions: Renal Cell Cancer;   Fatigue
20 Terminated A Phase II Optimization Study of BMS068645 and Sestamibi Planar Imaging
Conditions: Cardiovascular Disease;   Ischemic Heart Disease
Intervention: Drug: apadenoson

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years